NOVEMBER 2014
India is second only to China which is home to 92.3 million diabetics. Scientists from Harvard made a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes. Scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing beta cells equivalent in most every way to normally functioning beta cells. Stem cell researchers generated functional β cells from human pluripotent stem cells (hPSC) in vitro. When we say breakthrough in any disease or disorder, it is a moment of hope. Hoping for cure in near future!
Editorial of November’s issue more focused on controlling obesity and diabetes. In Japan, government is concerned about obesity of their people. They have certain rules to follow for that purpose and people are also health conscious and supportive in that regards. And as just they did in Japan, our government may step ahead in controlling obesity. It’s true that India is top in population and it is not easier to set such rules but we may step forward towards healthy India.
This issue contains reviews on finasteride in the treatment of female androgenic alopecia, antacids, and reviews on analytical methods for determination of cilnidipine, bromhexine, pravastatin and levosulpiride. It is also involved review on heparin, mitomycin, ethosomes and physicists in pharmaceutical industry.
November’s issue highlights researches like development of HPTLC method for the determination of scopolin, spectrophotometric method for simultaneous determination of sildenafil citrate and dapoxetine hydrochloride, stability indicating RP-HPLC method for estimation of manidipine, formulation and in vitro bioequivalence study of amoxycillin & potassium clavulanate, formulation and design of metformin extended release tablets and determination of nitaoxanide.
.png)
